Despite a scolding from President Trump over drug price hikes, drug giant Pfizer announced it will raise the prices of 41 medications in January. That’s 10% of its entire drug portfolio.
Pharmacy Best Practices
This comprehensive, pay-for-performance approach drives clinical quality and affordability.
Biosimilars hold great cost savings promises for payers and patients alike—but only if prescribers and patients are willing to make the switch.
Healthcare stakeholders can impact a patient’s health by leveraging available capabilities and resources to help achieve better health outcomes and address this opioid epidemic.
Cancer medication spending is unsustainable, but significant savings can be achieved just by reducing waste. Here’s how.
Better care at lower costs is the ultimate goal across healthcare today. Here’s how pharmacists can help.
Specialty pharmaceuticals make up a huge part of the current drug market, and their impact is only going to grow over the next few years.
How can payers cope with new, ultra-expensive therapies?
UPMC Health Plan has recently entered into two value-based contracts for medications related to treating diabetes and opioid addiction.
Innovative PBM performance-based pharmacy networks focus on reducing costs and Improving clinical outcomes